← Sectors/Sector model

Clinical & private care CL-04

UK Private & Mixed Dental Practices

How private and mixed dental practices make money, where chair time and treatment plans leak, and what transferable operators do differently.

A practice can be fully booked and still be economically fragile. Dentistry is the only sector in this series where the same chair hour can be sold under two incompatible payment regimes, so high utilisation proves only that the chair is occupied — not that the hour was worth occupying. The model is a diagnostic architecture, not a claim that every practice should convert to private.

Evidence read to 28 August 2026. Every figure below is tagged with where it came from.

00

At a glance

Dentists on the GDC register · January 2026 annual renewal

Observed

47,022

Annual register growth · 2026 renewal against 2025

Observed

3.2%

UK dental practices · Christie & Co Dental Market Review 2025

Observed

12,223

Adults not seen by an NHS dentist · 24 months to March 2026

Observed

28.2m

NHS Band 3 course of treatment · England, from 1 April 2026

Observed

£332.10

01

The sector thesis

Five claims that define how UK private and mixed dental practices should be understood.

Dentistry publishes more hard numbers than almost any sector Axial models. Registrant counts, practice counts, NHS activity volumes and the patient charge tariff are all exact and official. What none of them describes is the thing that decides whether a practice makes money: how much of a finite quantity of chair time is converted into accepted, completed, privately-priced treatment.

01

Two payment regimes compete for one chair

Economic identity

The same clinician and the same forty minutes can be sold at an administered NHS band charge or at a practice-set private fee. Mix enters the revenue identity as a weighting on realised value per chair hour, not as a separate revenue line.

02

The access gap is a demand condition, not a demand measurement

Observed + limitation

28.2 million adults did not see an NHS dentist in the 24 months to March 2026. That is a very large unattached population. It is not evidence of willingness or ability to pay private fees, and the model does not treat it as such.

03

Plan acceptance is the primary controllable conversion

Modelled mechanism

Roughly 45 pence in the pound of presented plan value is modelled as lost between presentation and collection. Acceptance is the only step that raises realised value per chair hour without requiring more chairs, more clinicians or more patients.

04

Ownership structure decides who can afford systems

Observed structure

7,955 of 12,223 practices are independently owned at one or two sites. 2,203 sit inside groups of thirty or more with central marketing, recall and reporting functions no single site can fund alone.

05

Financeability is an operating outcome, not a growth stage

Modelled maturity

Earnings become transferable when the principal is replaceable at the chair at a market rate and the recall book survives that replacement. Multiples of 6.5 to 9.5 times EBITDA are paid for that property, not for turnover.

What the sector publishes

  • UK dental practices12,223Observed
  • Independently owned, one to two sites65.1%Observed
  • Inside groups of thirty or more sites18.0%Observed
  • Adults seen by an NHS dentist, 24 months to March 202640%Observed
  • Associate-led practice EBITDA margin, 202523.7%Observed
  • Market-rate associate commission on gross fees35–45%Observed
  • Modelled realisation from presented plan value55%Modelled

Every one of those figures is exact, national and current, and not one of them is a business fact: a registrant is not a practice, a course of treatment is not a customer relationship, and an administered charge is not a price the practice chose. The sector is unusually well measured on the NHS side of the line and almost entirely unmeasured on the private side, which is where the margin is. It can be framed from public data. It cannot be diagnosed from it.

02

Scope, value chain & archetypes

Scope discipline prevents a market label becoming an incoherent economic model.

Scope

UK practices whose core economic activity is dental examination, treatment and continuing care delivered by GDC-registered clinicians, across the NHS, mixed and wholly private payment regimes. Excludes dental laboratories, orthodontic aligner platforms that do not own clinical delivery, training providers, professional bodies and equipment vendors.

The value chain

  1. 01NeedPain, symptom, recall due or cosmetic intent
  2. 02DiscoverySearch, directory, recommendation or existing list
  3. 03RegistrationPractice list, plan or one-off attendance
  4. 04ExaminationCharting, imaging and clinical assessment
  5. 05PlanOptions presented, priced and consented
  6. 06CompletionScheduled, delivered and paid
  7. 07RecallInterval review, membership and reactivation

Archetype configurations

NHS-weighted single site

Three surgeries, high volume, delivering against a UDA contract. No pricing power whatever: the tariff is administered nationally. Economics are decided entirely by delivery efficiency.

Mixed community practice

Four surgeries, roughly balanced NHS and private. The modal UK shape and the most exposed to mix drift in either direction.

Private squeeze-out

Converted from mixed, membership plan attached. Has pricing power and has taken on the acceptance and retention risk that comes with it.

Specialist / referral

Implants, orthodontics or endodontics. Fed by referral flow rather than patient flow, with the highest realised value per chair hour and the widest outcome range.

Multi-site group

Three to twenty-nine sites with a central function. Value depends on whether the centre improves repeatability or merely adds cost.

Corporate platform

Thirty or more sites. Capital, procurement and brand at a scale no independent can match, carrying central overhead no independent has to.

Where value accumulates

28%

Chair time delivery

27%

Treatment plan acceptance

23%

Recall & membership annuity

Data / financeability

Value in dentistry accumulates late. Delivering chair time is necessary and confers no advantage — every practice does it. Advantage begins at plan acceptance, compounds through the recall and membership book, and is realised only when that book is legible enough to survive a change of principal.

A practice that owns clinical delivery but not acceptance or recall has built the expensive half of the value chain and rented out the profitable half.

Including all three payment regimes is a deliberate choice against the grain of most sector commentary, which treats NHS and private dentistry as separate markets. They are not separate markets. They are two prices for the same chair hour, competing inside the same building and usually inside the same appointment book — which is why the mixed practice sits at the centre of this model rather than at its edge. The six archetypes are configurations, not stages of one growth path: each has a different binding constraint and a different characteristic failure.

03

Market structure & demand

Demand is enormous and measured; private willingness to pay is neither.

UK dentistry has a measurement problem in exactly one place, and it happens to be the commercially decisive one. Practice counts, ownership structure, registrant numbers and NHS activity are all published and exact. Private fee levels, private practice counts and chair utilisation are published nowhere.

Demand segments

NHS patient, charge-paying

Pays an administered band charge. Price-insensitive by construction — the charge is national and identical everywhere.

NHS patient, exempt

Under-18s, pregnant women, new mothers and certain benefit recipients. Consumes chair time and generates contract activity but no patient charge.

Mixed-practice private payer

Buys private treatment inside a practice that also holds an NHS contract. The largest and least documented private segment.

Membership plan member

Pays a monthly fee for defined preventive care. The only genuinely contracted revenue in most practices.

Fee-per-item private payer

No plan, no NHS relationship. Highest realised value and the weakest forward visibility.

Referred specialist case

Arrives with a diagnosis and an intent. Very high value per chair hour, acquisition governed by referrer relationships rather than marketing.

The demand regime

Underlying clinical needVery high
NHS access availabilityConstrained
Private willingness to payNot established
Price sensitivity, elective workHigh
Switching cost once registeredModerate

Commercial conclusion

Demand for dentistry is not in question and never has been. What is in question is how much of a very large, partly unattached population will pay a practice-set fee rather than wait, travel or go without. That is a conversion question, not a market-size question, and it is answered practice by practice.

Structural anchors

Adults seen by an NHS dentist · 24 months to March 2026

Observed

18.8m

Courses of treatment delivered · 2025/26, up 6.2%

Observed

37.6m

Units of dental activity delivered · 2024/25

Observed

73m

National private fee distribution

Not established

What this model does not claim

Not established

This model does not publish a UK private dental market size, a national average private fee, or a count of wholly private practices. No regulator or trade body collects private fee data, and the 12,223 practice count records practices rather than payment regimes. Figures circulating online as national private averages are aggregator estimates without a stated sample and are not cited here.

The most quoted number in UK dentistry — three in five adults without a recent NHS appointment — is accurate, official and routinely misused. It establishes that a very large population has no current NHS dental relationship, not that those people are private customers in waiting; the population that cannot get an NHS appointment overlaps heavily with the population least able to absorb a £700 crown. The defensible reading is narrower: the access gap does not create demand, it removes the free option that previously suppressed private conversion. A practice acting on it should measure local conversion, not national headroom.

04

Revenue architecture

Two payment regimes compete for the same finite chair hour.

Revenue begins with a bookable chair hour and improves in quality as more of it becomes contracted ahead of delivery — through membership plans, scheduled multi-visit treatment and governed recall rather than through one-off attendance.

Revenue layers

Administered NHS activity

Band charges plus contract value. Volume without pricing power; predictable and capped.

Practice-set private treatment

Examination, hygiene, restorative and cosmetic work at fees the practice controls.

Contracted recurring

Membership plans and scheduled treatment courses. The only revenue visible before it is delivered.

Revenue identity

Practice revenue = bookable chair hours × utilisation × realised value per chair hour

Price anchors · administered and modelled

NHS course-of-treatment bands · England, from 1 April 2026

£76.60
£27.90£332.10

Modelled realised value per chair hour · by archetype

£178
£105£470

NHS treatment bands, national and administered · England

Observed · official tariff

3 / 3

No regulator or trade body collects UK private dental fee data.

Not established

No private tariff

Modelled realisation waterfall

Presented plan value100%
After acceptance74%
After deferral65%
After failure to attend59%
Realised fee55%

What the waterfall shows

The dental waterfall loses almost nothing to discounting and a great deal to acceptance. Twenty-six pence in the pound never survives the conversation in which the plan is presented; a further nineteen is lost to deferral and non-attendance after the patient has already said yes. Only four pence is given away on price. That distribution tells an operator exactly where to intervene, and it is not on the price list.

The revenue-quality path

  1. 01Low visibilityFee-per-item private attendance
  2. 02ModerateScheduled multi-visit treatment course
  3. 03HigherMembership plan and governed recall
  4. 04Platform qualityDiversified cohorts and site-level reporting

The administered bands are exact and universal; the private corridor is modelled and carries no claim of national representativeness. Realised value per chair hour depends on appointment length, clinician seniority, NHS and private mix, plan acceptance, attendance and local cost base — none of which is published.

Most dental commentary is organised around the patient or the course of treatment, and both are the wrong unit. The patient is not what the practice is short of; the course of treatment is an administrative artefact of the NHS contract with no private equivalent. What the practice is short of is chair time — finite, countable, and consumed identically by both payment regimes. Choosing it as the unit makes the NHS-versus-private question tractable: at a modelled £120 per chair hour NHS-weighted and £275 private, the same physical capacity produces materially different revenue with no change to the building or the appointment book.

05

Unit economics

Modelled archetype corridors, not reported sector averages.

The same sector produces very different economics when utilisation, mix, plan acceptance, clinician cost and overhead absorption change. Principal clinical time is normalised to a market replacement rate before economic EBITDA, which is why these figures are not comparable with reported net profit per principal.

NHS-weighted · 3 surgeries

Revenue · downside, base, high

£430k · £520k · £610k

Normalised EBITDA

Downside£52k
Base£91k
High£128k

No pricing lever exists. Everything depends on delivery efficiency against an administered tariff.

Mixed community · 4 surgeries

Revenue · downside, base, high

£790k · £960k · £1.14m

Normalised EBITDA

Downside£158k
Base£211k
High£274k

The modal UK practice. Mix drift in either direction moves margin faster than any cost line.

Private squeeze-out · 3 surgeries

Revenue · downside, base, high

£870k · £1.06m · £1.27m

Normalised EBITDA

Downside£200k
Base£270k
High£356k

Highest margin and highest exposure: every plan must be earned, with no tariff floor beneath it.

Base central model: 1,610 bookable chair hours per surgery per year · 84% utilisation · £178 modelled realised value per chair hour

Three break-evens

Contribution break-even

Clinician and materials cost covered

EBITDA break-even

Support staff, premises and practice overhead covered

Cash-survival break-even

Working capital, surgery refurbishment and equipment capex recognised

All values are modelled archetype configurations. Actual results depend on location, mix, employment model, principal remuneration, tax treatment, utilisation, capex and working capital. Christie & Co report a 23.7% associate-led EBITDA margin for 2025; the corridors above bracket that figure but are not derived from it.

Each archetype is shown as a downside, base and high-performing configuration rather than a point estimate, and the spread inside one archetype is wider than the gap between adjacent archetypes — how well a configuration is run matters more than which configuration it is. Principal clinical time is normalised to a market replacement rate before economic EBITDA, which is why these corridors cannot be compared with NASDAL’s net profit per principal of roughly £196,000. The two measures answer different questions: one asks what the owner takes home, the other what would survive the owner leaving.

06

Capacity & the overhead staircase

Capacity is bookable chair hours, and it is consumed whether or not it earns.

Chair time binds before patient demand in every released archetype. A surgery without a clinician in it earns nothing and costs the same; a clinician without a surgery cannot work at all. Recruitment, diary design, attendance and plan scheduling determine whether physical infrastructure is economically used.

The capacity equation

Bookable chair hours

Surgeries × clinical sessions × session length × clinical weeks. Modelled at 1,610 hours per surgery per year.

Utilisation

The share of bookable hours actually delivered. Lost to unfilled diary, failure to attend, short-notice cancellation and clinician absence.

Realised value per chair hour

Set by NHS and private mix, treatment mix, plan acceptance and clinician seniority. The term with the widest available range.

Utilisation of bookable chair hours, by archetype

NHS-weighted · 3 surgeries88% util
Mixed community · 4 surgeries84% util
Private squeeze-out · 3 surgeries80% util
Specialist / referral · 2–3 surgeries74% util
Modelled practical ceiling92% util

Utilisation falls as realised value rises, and the inverse relationship is not an accident. Higher-value private work carries longer appointments, higher cost per failed slot and acceptance risk that NHS band work does not. The practices earning most per hour have the most idle chair time to lose. No published source records UK dental chair utilisation; every figure here is modelled.

Modelled realised value per chair hour, mixed archetype

Modelled

£178

Against 1,610 bookable hours per surgery, each percentage point of utilisation is worth roughly £2,865 of revenue per surgery per year at close to full contribution, because the cost of the hour is already committed.

The overhead staircase

  1. 01Second clinicianNursing cover and diary coordination
  2. 02Third surgeryDecontamination capacity and equipment servicing
  3. 03Practice managerPrincipal steps back from administration
  4. 04Treatment coordinatorAcceptance becomes a role, not a by-product
  5. 05Second siteCentral recall, reporting and marketing
The question is never whether to grow but which step is next and what has to be true before it pays for itself. Each rung is a fixed cost added ahead of the revenue that justifies it, and the treatment coordinator step is the one most often skipped and most often decisive.

Utilisation attracts less attention than fee levels because it appears on no price list and no software reports it by default, yet it is the second widest modelled mover of EBITDA in the sector. At 1,610 bookable hours and £178 realised per hour, each point is worth about £2,865 per surgery per year: on four surgeries, moving from 84% to 88% is roughly £46,000 of revenue arriving with almost no additional cost. The same arithmetic runs backwards, and a practice quietly operating at 78% has given up a comparable sum with no visible event — no lost patients, no fee reduction, just gaps.

07

Customer journey & cohorts

Acceptance, not enquiry, is where dental revenue is won and lost.

Dentistry does not usually have an enquiry problem. It has an acceptance and scheduling problem. The pipeline below is where the sector’s contribution is decided, and the largest single loss occurs after the patient is already sitting in the chair.

The pipeline

  1. 01EnquiryCall, form or walk-in
  2. 02RegistrationAdded to the list or plan
  3. 03ExaminationAttended and charted
  4. 04Plan presentedOptions priced and explained
  5. 05Plan acceptedConsented and scheduled
  6. 06CompletedDelivered, paid, recall set

Episode corridors

Modelled plan acceptance rate, mixed archetype

Modelled

74%

Modelled realisation, presented value to collected fee

Modelled

55%

Modelled loss to failure to attend and short-notice cancellation

Modelled

6%

National acceptance benchmark

Not established

Lifetime value in dentistry is unusually long and unusually easy to overstate. A retained patient may attend for decades, which makes almost any acquisition cost look justifiable on a spreadsheet. The model treats lifetime value as a retention outcome to be measured after the fact, never as a forward assumption used to justify present spend.

The dataset a diagnosis needs

  • Bookable chair hours
  • Delivered chair hours
  • New patient examinations
  • Plans presented
  • Plan value presented
  • Plans accepted
  • Accepted value scheduled
  • Failure-to-attend rate
  • Recall adherence rate
  • Plan members and churn
  • Revenue by clinician
  • NHS / private revenue split

Ask a practice for these twelve figures. Most can produce four or five without difficulty and cannot produce the rest at all. Which ones are missing is itself the diagnosis, because the absent numbers are almost always the ones bracketing the acceptance step.

The modelled waterfall loses 26 points at acceptance, a further nine to deferral, six to non-attendance and four to price. The ordering is the finding: dentistry loses six times more value in the conversation where a plan is presented than it does on discounting. That runs against the instinct of a practice under margin pressure, which is to review the fee list — raising fees on plans that are not being accepted increases the value of the loss without changing its cause. Acceptance is also almost entirely systematic rather than clinical. What to recommend is a clinical decision; whether it is written down, priced, financed, followed up and scheduled is not.

08

The financeability ladder

A fifth of the market has central functions the other two thirds do not.

Dentistry has a more active transaction market than any other sector in this series. Christie & Co advised on, agreed or sold 1,241 practices in 2025 with a combined value of £1.68 billion. That means the financeability ladder below is not theoretical: it is priced, repeatedly, by real buyers.

01

Principal-dependent

The principal delivers most clinical income and holds the patient relationships. Earnings are a job, not a business.

Cost principal clinical time at a market associate rate and see what remains.

02

Associate-supported

Associates deliver a meaningful share of clinical income at 35–45% commission. Normalised earnings become visible for the first time.

Measure revenue and contribution by clinician, not by practice.

03

Systematised acceptance

Plan presentation, follow-up and scheduling run as a defined process with a measured conversion rate.

Instrument plan value presented, accepted and scheduled.

04

Contracted recall book

Membership plans and governed recall make a material share of next year’s revenue visible today.

Report plan membership, churn and margin per member per year.

05

Transferable platform

Site economics are legible, the principal is replaceable at the chair, and the recall book survives that replacement.

This is the property that 6.5 to 9.5 times EBITDA is actually paid for.

Consolidation signal

12,223 practices; 2,203 inside groups of thirty or more sites, led by mydentist at 511, Bupa Dental at 380, PortmanDentex at 376 and Rodericks at 226. In 2024, 74% of completed deals went to independent operators, 11% to smaller groups and 15% to corporates — and every buyer class moved in the same direction, away from NHS-weighted practices and toward mixed and private models. Average price paid rose 2.9% across 2025.

Multiples of 6.5 to 9.5 times EBITDA are observed and reported, but they are paid for normalised, transferable earnings on the rung-five definition above. A practice trading at rung one has no EBITDA in that sense to multiply, regardless of turnover. This model does not value practices and no figure here should be read as a valuation.

The consolidation numbers are usually read as a story about scale, and they are not — corporates took 15% of completed deals in 2024 while independents took 74%. The dominant buyer of a UK dental practice is still another dentist. What every buyer class shares is a direction rather than a size: all three moved toward mixed and private practices and away from NHS-weighted ones. They are buying pricing power and the acceptance systems that convert it, which is why rung three is the hinge and the rung most often skipped.

09

Risk & sensitivity

For the central archetype, plan acceptance and revenue mix are the widest modelled movers.

Modelled effect on normalised EBITDA of a one-standard-step move in each driver, central mixed archetype, widest first. The two widest movers are both revenue-side, which is why this model does not lead with cost control.

Modelled EBITDA sensitivity

Plan acceptance ratewidest
Realised value per chair hourvery wide
Clinician cost percentagewide
Chair utilisationwide
Support staff cost percentagemoderate
Lab and materials percentagenarrow

Reading the order

Acceptance and mix dominate together. A practice that improves acceptance by four points and realised value per chair hour by £15 moves further than one that removes every penny of lab and materials waste. Cost control is necessary and it is not where the range is.

Scenarios

Downside · NI and wage pressure

Employers’ National Insurance and wage inflation land on a cost base where clinician and support staff costs run to 60–65% of revenue. Acceptance flat. Margin compresses toward the bottom of the corridor.

Base · mix drift held

Utilisation 84%, acceptance 74%, realised value £178 per chair hour. Roughly £960k of revenue and 22% normalised EBITDA on four surgeries.

High-performing · acceptance systematised

Acceptance improves four points and realised value £15 per hour on unchanged capacity. Roughly £120k of additional revenue at close to full contribution.

Scaled winner · legible multi-site

Site economics stay visible as sites are added and central recall improves repeatability rather than adding cost. Rare, and the only version of scale that reliably pays.

Indicators worth watching

  • Delivered against bookable chair hours
  • Plan value presented per month
  • Plan acceptance rate by clinician
  • Accepted value scheduled within 30 days
  • Failure-to-attend rate
  • Recall adherence at 9 and 15 months
  • Plan membership net movement
  • NHS / private revenue mix drift
  • Clinician vacancy days per surgery
These are modelled sensitivities on archetype configurations, not forecasts and not causal claims. A correlation between acceptance rate and margin in the model does not establish that a given practice will improve margin by pursuing acceptance; it establishes where to look first. Causation has to be tested on the operator’s own data before any intervention is priced.

Dental cost lines are both bounded and already tightly managed — associate commission sits in a 35–45% band set by a competitive labour market, and lab and materials are a single-digit to low-double-digit percentage NASDAL reports as falling. Acceptance has no such bound. A practice presenting £900,000 of plan value at 68% acceptance and one presenting the same value at 80% differ by £108,000 of revenue at close to full contribution, with identical premises, staff and equipment. No cost programme available to a dental practice produces a comparable movement.

10

AI & operating systems

Technology creates value only when it changes a measurable operating driver.

Technology creates value in dentistry only when it moves one of the drivers on the previous page. This is not a software catalogue. Each intervention below names the driver it moves, the operator data it requires and the commercial test that decides whether it worked.

The drivers an intervention has to move

Chair utilisation

Delivered against bookable hours

Plan acceptance

Presented value converted

Realised value / hour

Mix and treatment composition

Recall adherence

Returned within interval

Clinician cost %

Commission and vacancy

Missed-call and out-of-hours capture

Driver: utilisation. A new-patient enquiry that reaches voicemail during a clinical session is the cheapest lost chair hour in the sector. Test: contact rate and booked rate on recovered enquiries.

Structured plan presentation and follow-up

Driver: acceptance. Written plan, priced options, finance offered before the patient leaves, governed follow-up on anything not accepted. Test: acceptance rate by clinician, before and after.

Same-appointment scheduling of accepted work

Driver: acceptance and utilisation together. Accepted treatment that leaves the building unscheduled is the nine-point deferral loss in the waterfall. Test: accepted value scheduled within 30 days.

Short-notice list and deposit policy

Driver: utilisation. A governed cancellation list converts a failed appointment into a filled one rather than an empty surgery. Test: failure-to-attend rate and slots refilled.

Recall governance and lapsed reactivation

Driver: recall adherence. The existing patient list is the cheapest source of examined patients a practice will ever have. Test: recall adherence at 9 and 15 months, reactivation yield.

Clinician-level contribution reporting

Driver: clinician cost and mix. Revenue by clinician is common; contribution by clinician after commission, materials and chair time is not. Test: contribution per clinical hour by clinician.

The commercial test that governs all six

Every intervention must name the driver it moves, the figure that will change, the measurement window and the threshold below which it is judged not to have worked — before it is built. An intervention that cannot state those four things in advance is not an economic intervention and should not be bought as one.

Sequence

Measure first, intervene second, re-measure third. In dentistry the correct order is almost always: instrument acceptance, fix scheduling of accepted work, then attack utilisation, then look at cost. Reversing that order produces a practice with excellent cost control and an unmanaged conversion process.

Almost every dental practice can be sold marketing that generates more enquiries, and for most that is the wrong first move: more enquiries into an unmanaged acceptance process produce more presented plan value and the same 26-point loss. Instrumenting acceptance is unglamorous and cheap — plan value presented, plans accepted, accepted value scheduled, three fields most practice management systems can already hold and few populate consistently. None of the six interventions is a clinical system, and five of the six operate entirely on demand the practice has already acquired and paid for.

11

Maturity — from model to diagnosis

The sector model becomes commercially useful when a named operator is scored against it.

The sector model becomes commercially useful at the moment a named operator is scored against it. The eight dimensions below convert everything in this model into a diagnostic that can be completed in a single working session with the practice’s own data.

Eight dimensions

Capacity visibility

Bookable against delivered chair hours, stated and reconciled

Acceptance discipline

Plan value presented, accepted and scheduled, measured by clinician

Mix control

NHS and private revenue split, tracked and deliberate rather than drifting

Recall governance

Adherence measured at interval; lapsed patients systematically worked

Revenue quality

Share of next quarter contracted through plans and scheduled courses

Clinician economics

Contribution per clinical hour by clinician, after commission

Principal replaceability

Clinical income deliverable at market rate without the principal

Data and reporting

The twelve-item dataset producible without a special exercise

Scored one to five

  1. 1Absent — the figure is not held
  2. 2Anecdotal — known by feel, not recorded
  3. 3Recorded — captured but not reviewed
  4. 4Managed — reviewed on a cadence with an owner
  5. 5Governed — targeted, forecast and acted on

What the scoring needs

  • Bookable and delivered chair hours
  • Plan value presented and accepted
  • Accepted value scheduled in 30 days
  • Failure-to-attend rate
  • NHS / private revenue split
  • Plan membership and churn
  • Revenue and contribution by clinician
  • Recall adherence at interval
A practice scoring at levels one and two across acceptance, capacity visibility and data does not have a marketing problem, whatever it believes. It has an instrumentation problem, and instrumentation is both cheaper to fix and faster to prove than demand generation. Scoring the operator against these eight dimensions is what turns this sector model into a specific, priced piece of work.

The dimensions are scored against the practice’s own figures rather than against an interview — a principal’s assessment of their recall governance and the adherence figure their software produces are frequently several levels apart. Where a figure cannot be produced the dimension scores one, which is not a penalty but the finding. The output is a profile rather than a total: a practice at level four on capacity visibility and level one on acceptance discipline needs something quite different from one with the reverse profile, and an aggregate score would conceal exactly the difference that matters.

This is a sector-level economic model, not operator-level advice. Built from regulatory, payer and transactional evidence, the administered NHS tariff, five archetype configurations and the Axial Economic OS. Observed facts, inferences, estimates and modelled values stay visibly separate. Evidence was read to 28 August 2026. Modelled values are archetype configurations rather than reported sector averages or benchmarks, and nothing here is a forecast. Where the sector supports no defensible figure the model says Not established rather than substituting a plausible one. A named-operator diagnosis confirms every relevant figure against that operator's own data before any intervention is priced.

See where your business sits against this model.

The model is the sector's. The numbers are yours. The diagnostic prices the gap between the two.